Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation

Shin'ichi Saito, Xiu Fen Liu, Keiju Kamijo, Razi Raziuddin, Takashi Tatsumoto, Isamu Okamoto, Xiaoyan Chen, Chong Chou Lee, Matthew V. Lorenzi, Naoya Ohara, Toru Miki

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The human ECT2 protooncogene encodes a guanine nucleotide exchange factor for the Rho GTPases and regulates cytokinesis. Although the oncogenic form of ECT2 contains an N-terminal truncation, it is not clear how the structural abnormality of ECT2 causes malignant transformation. Here we show that both the removal of the negative regulatory domain and alteration of subcellular localization are required to induce the oncogenic activity of ECT2. The transforming activity of oncogenic ECT2 was strongly inhibited by dominant negative Rho GTPases, suggesting the involvement of Rho GTPases in ECT2 transformation. Although deletion of the N-terminal cell cycle regulator-related domain (N) of ECT2 did not activate its transforming activity, removal of the small central domain (S), which contains two nuclear localization signals (NLSs), significantly induced the activity. The ECT2 N domain interacted with the catalytic domain and significantly inhibited the focus formation by oncogenic ECT2. Interestingly, the introduction of the NLS mutations in the S domain of N-terminally truncated ECT2 dramatically induced the transforming activity of this otherwise non-oncogenic derivative. Among the known Rho GTPases expressed in NIH 3T3 cells, RhoA was predominantly activated by oncogenic ECT2 in vivo. Therefore, the mislocalization of structurally altered ECT2 might cause the untimely activation of cytoplasmic Rho GTPases leading to the malignant transformation.

Original languageEnglish
Pages (from-to)7169-7179
Number of pages11
JournalJournal of Biological Chemistry
Volume279
Issue number8
DOIs
Publication statusPublished - Feb 20 2004
Externally publishedYes

Fingerprint

rho GTP-Binding Proteins
Cytokinesis
Deregulation
Nuclear Localization Signals
Guanine Nucleotide Exchange Factors
NIH 3T3 Cells
Nucleotides
Catalytic Domain
Cell Cycle
Chemical activation
Cells
Derivatives
Mutation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation. / Saito, Shin'ichi; Liu, Xiu Fen; Kamijo, Keiju; Raziuddin, Razi; Tatsumoto, Takashi; Okamoto, Isamu; Chen, Xiaoyan; Lee, Chong Chou; Lorenzi, Matthew V.; Ohara, Naoya; Miki, Toru.

In: Journal of Biological Chemistry, Vol. 279, No. 8, 20.02.2004, p. 7169-7179.

Research output: Contribution to journalArticle

Saito, S, Liu, XF, Kamijo, K, Raziuddin, R, Tatsumoto, T, Okamoto, I, Chen, X, Lee, CC, Lorenzi, MV, Ohara, N & Miki, T 2004, 'Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation', Journal of Biological Chemistry, vol. 279, no. 8, pp. 7169-7179. https://doi.org/10.1074/jbc.M306725200
Saito, Shin'ichi ; Liu, Xiu Fen ; Kamijo, Keiju ; Raziuddin, Razi ; Tatsumoto, Takashi ; Okamoto, Isamu ; Chen, Xiaoyan ; Lee, Chong Chou ; Lorenzi, Matthew V. ; Ohara, Naoya ; Miki, Toru. / Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 8. pp. 7169-7179.
@article{75854322ec8e4f5b91b3b687072d2e97,
title = "Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation",
abstract = "The human ECT2 protooncogene encodes a guanine nucleotide exchange factor for the Rho GTPases and regulates cytokinesis. Although the oncogenic form of ECT2 contains an N-terminal truncation, it is not clear how the structural abnormality of ECT2 causes malignant transformation. Here we show that both the removal of the negative regulatory domain and alteration of subcellular localization are required to induce the oncogenic activity of ECT2. The transforming activity of oncogenic ECT2 was strongly inhibited by dominant negative Rho GTPases, suggesting the involvement of Rho GTPases in ECT2 transformation. Although deletion of the N-terminal cell cycle regulator-related domain (N) of ECT2 did not activate its transforming activity, removal of the small central domain (S), which contains two nuclear localization signals (NLSs), significantly induced the activity. The ECT2 N domain interacted with the catalytic domain and significantly inhibited the focus formation by oncogenic ECT2. Interestingly, the introduction of the NLS mutations in the S domain of N-terminally truncated ECT2 dramatically induced the transforming activity of this otherwise non-oncogenic derivative. Among the known Rho GTPases expressed in NIH 3T3 cells, RhoA was predominantly activated by oncogenic ECT2 in vivo. Therefore, the mislocalization of structurally altered ECT2 might cause the untimely activation of cytoplasmic Rho GTPases leading to the malignant transformation.",
author = "Shin'ichi Saito and Liu, {Xiu Fen} and Keiju Kamijo and Razi Raziuddin and Takashi Tatsumoto and Isamu Okamoto and Xiaoyan Chen and Lee, {Chong Chou} and Lorenzi, {Matthew V.} and Naoya Ohara and Toru Miki",
year = "2004",
month = "2",
day = "20",
doi = "10.1074/jbc.M306725200",
language = "English",
volume = "279",
pages = "7169--7179",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation

AU - Saito, Shin'ichi

AU - Liu, Xiu Fen

AU - Kamijo, Keiju

AU - Raziuddin, Razi

AU - Tatsumoto, Takashi

AU - Okamoto, Isamu

AU - Chen, Xiaoyan

AU - Lee, Chong Chou

AU - Lorenzi, Matthew V.

AU - Ohara, Naoya

AU - Miki, Toru

PY - 2004/2/20

Y1 - 2004/2/20

N2 - The human ECT2 protooncogene encodes a guanine nucleotide exchange factor for the Rho GTPases and regulates cytokinesis. Although the oncogenic form of ECT2 contains an N-terminal truncation, it is not clear how the structural abnormality of ECT2 causes malignant transformation. Here we show that both the removal of the negative regulatory domain and alteration of subcellular localization are required to induce the oncogenic activity of ECT2. The transforming activity of oncogenic ECT2 was strongly inhibited by dominant negative Rho GTPases, suggesting the involvement of Rho GTPases in ECT2 transformation. Although deletion of the N-terminal cell cycle regulator-related domain (N) of ECT2 did not activate its transforming activity, removal of the small central domain (S), which contains two nuclear localization signals (NLSs), significantly induced the activity. The ECT2 N domain interacted with the catalytic domain and significantly inhibited the focus formation by oncogenic ECT2. Interestingly, the introduction of the NLS mutations in the S domain of N-terminally truncated ECT2 dramatically induced the transforming activity of this otherwise non-oncogenic derivative. Among the known Rho GTPases expressed in NIH 3T3 cells, RhoA was predominantly activated by oncogenic ECT2 in vivo. Therefore, the mislocalization of structurally altered ECT2 might cause the untimely activation of cytoplasmic Rho GTPases leading to the malignant transformation.

AB - The human ECT2 protooncogene encodes a guanine nucleotide exchange factor for the Rho GTPases and regulates cytokinesis. Although the oncogenic form of ECT2 contains an N-terminal truncation, it is not clear how the structural abnormality of ECT2 causes malignant transformation. Here we show that both the removal of the negative regulatory domain and alteration of subcellular localization are required to induce the oncogenic activity of ECT2. The transforming activity of oncogenic ECT2 was strongly inhibited by dominant negative Rho GTPases, suggesting the involvement of Rho GTPases in ECT2 transformation. Although deletion of the N-terminal cell cycle regulator-related domain (N) of ECT2 did not activate its transforming activity, removal of the small central domain (S), which contains two nuclear localization signals (NLSs), significantly induced the activity. The ECT2 N domain interacted with the catalytic domain and significantly inhibited the focus formation by oncogenic ECT2. Interestingly, the introduction of the NLS mutations in the S domain of N-terminally truncated ECT2 dramatically induced the transforming activity of this otherwise non-oncogenic derivative. Among the known Rho GTPases expressed in NIH 3T3 cells, RhoA was predominantly activated by oncogenic ECT2 in vivo. Therefore, the mislocalization of structurally altered ECT2 might cause the untimely activation of cytoplasmic Rho GTPases leading to the malignant transformation.

UR - http://www.scopus.com/inward/record.url?scp=10744225152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744225152&partnerID=8YFLogxK

U2 - 10.1074/jbc.M306725200

DO - 10.1074/jbc.M306725200

M3 - Article

C2 - 14645260

AN - SCOPUS:10744225152

VL - 279

SP - 7169

EP - 7179

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 8

ER -